跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 388,836 条关于
“Scalp and Body Psoriasis”
全部
388,836
临床试验
341,438
药物
4,368
机构
2,247
资讯
40,783
去年
FDA Accepts Roflumilast Foam sNDA for Scalp and Body Psoriasis Treatment
去年
FDA Anticipated to Decide on Dupixent, Pz-cel, and Roflumilast Foam for Dermatologic Conditions by Mid-2025
去年
Dermatology News Roundup: Bimzelx Expansion, Zoryve sNDA, and HS Insights
去年
Roflumilast Foam Shows Promise in Reducing Itch and Improving Quality of Life for Psoriasis Patients
去年
Deucravacitinib Demonstrates Efficacy for Scalp and Overall Psoriasis in Phase 3 and Real-World Studies
去年
Arcutis Biotherapeutics Reports Strong Q3 2024 Revenue Growth Driven by ZORYVE Franchise
2年前
Ixekizumab Shows Sustained Efficacy in Treating Psoriasis in Challenging Body Areas Over 5 Years
9个月前
FDA Expands Dermatology Drug Labels in 2025 with Five New Indications Across Multiple Skin Conditions
去年
Bristol Myers Squibb Announces Positive Data for Sotyktu in Moderate to Severe Psoriasis
去年
Guselkumab Demonstrates High Efficacy for Psoriasis Treatment Across All Skin Tones in Landmark VISIBLE Trial
第 1 页,共 4079 页
上一页
下一页